Milan Paleja to Head Novartis India's Pharmaceuticals Business
Novartis India has appointed Mr. Milan Paleja as its new President. He will succeed Mr. Jawed Zia, who left the drug maker in March for rival Abbott India. Mr. Paleja, previously President and head of pharmaceuticals for Novartis Indonesia, will also head Novartis India’s pharmaceutical business, according to a company release. “While in Indonesia, he pioneered innovative access models, turned around the business and laid the foundation for future growth,” stated the release. He is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Best Service Pharmaceutical Producer CAS 2381089-83-2 Retatrutide 5mg Weight Loss Peptide
$70/MT FOB
2026-07-04
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Beyond Compliance: Building Quality Maturity
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
-
India Imposes Anti-Dumping Duties on Chinese vitamin A Palmitate and Insoluble Sulfur Products
-
Indian Government Increases Excise Duty on Petrol and Diesel
Recommend Reading
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
In early November, the phosphate market in China showed a strong performance (Nov. 1-10)
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Supply-Demand Gap Widens, Lithium Carbonate Prices Approach Year-to-Date High
-
Shipment Pressure Eases Locally; PC Prices Show Mixed Trends in Early November
-
Geopolitical Expectations Reversal Leads to Severe Oil Market Volatility, Oil Prices Plunge Over 11%